MENU
+Compare
TMDX
Stock ticker: NASDAQ
AS OF
Aug 29 closing price
Price
$114.96
Change
-$1.76 (-1.51%)
Capitalization
3.92B

TMDX stock forecast, quote, news & analysis

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states... Show more

TMDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TMDX showed earnings on July 30, 2025. You can read more about the earnings report here.
Interact to see
Advertisement
A.I.Advisor
a Summary for TMDX with price predictions
Aug 29, 2025

TMDX sees MACD Histogram just turned negative

TMDX saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on August 21, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 51 instances where the indicator turned negative. In of the 51 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on TMDX as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

TMDX moved below its 50-day moving average on August 19, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for TMDX crossed bearishly below the 50-day moving average on August 28, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TMDX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TMDX broke above its upper Bollinger Band on August 01, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TMDX advanced for three days, in of 298 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 320 cases where TMDX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TMDX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.315) is normal, around the industry mean (60.381). P/E Ratio (57.769) is within average values for comparable stocks, (38.412). TMDX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.729). TMDX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (8.190) is also within normal values, averaging (81.129).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Boston Scientific Corp (NYSE:BSX), Medtronic plc (NYSE:MDT), Edwards Lifesciences Corp (NYSE:EW).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 5.64B. The market cap for tickers in the group ranges from 1.86K to 230.89B. ABT holds the highest valuation in this group at 230.89B. The lowest valued company is CSAY at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was 1%. For the same Industry, the average monthly price growth was 6%, and the average quarterly price growth was 10%. CSDX experienced the highest price growth at 82%, while TRIB experienced the biggest fall at -81%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was -1%. For the same stocks of the Industry, the average monthly volume growth was 46% and the average quarterly volume growth was 25%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 76
Price Growth Rating: 61
SMR Rating: 88
Profit Risk Rating: 92
Seasonality Score: -20 (-100 ... +100)
View a ticker or compare two or three
TMDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of a proprietary system for preserving human organs for transplant

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
200 Minuteman Road
Phone
+1 978 552-0900
Employees
584
Web
https://www.transmedics.com